Skip to content

Analysis of preoperative nutritional status in clinical stage I-III resectable esophageal cancer patients and the impact of preoperative individualized nutritional therapy on the overall incidence of postoperative complications

Analysis of preoperative nutritional status in clinical stage I-III resectable esophageal cancer patients and the impact of preoperative individualized nutritional therapy on the overall incidence of postoperative complications

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090755
Enrollment
Unknown
Registered
2024-10-12
Start date
2022-06-20
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

Experimental group:Conduct nutrition education and develop personalized nutrition treatment plans, and monitor and follow up daily
control group:none

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clinical stage I-III resectable esophageal cancer patients aged 18-80 years old; 2. Diagnosed as esophageal cancer through preoperative gastroscopy and pathological examination; 3. Patients undergoing minimally invasive esophagectomy and open esophagectomy for esophageal cancer;

Exclusion criteria

Exclusion criteria: 1. Patients who are completely unable to eat orally or have severe malnutrition at the time of diagnosis; 2. Patients with high catabolic metabolic status such as active tuberculosis, uncontrolled hyperthyroidism, and patients with decreased basal metabolic rate such as hypothyroidism; 3. Patients with severe heart, liver, and kidney dysfunction and severe chronic obstructive pulmonary disease; 4. Patients implanted with metal materials such as cardiac stents and pacemakers; 5. Patients with confusion, cognitive impairment, etc. who are unable to understand and sign informed consent forms.

Design outcomes

Primary

MeasureTime frame
Surgical site infection;Anastomotic fistula;Chylothorax;empyema;The progression of underlying diseases;

Secondary

MeasureTime frame
NRS2002;PG-SGA;Arrhythmias;

Countries

China

Contacts

Public ContactZhao Yuetong

Peking University First Hospital

lavendaress@vip.qq.com+86 136 5114 5885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026